Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD0YI
|
||||
| Drug Name |
N1-3-[5-(2-Methyl-6-[(3-morpholinopropyl)amino]-4-pyrimidinylamino)-1H-3-pyrazolyl]phenyl-1-benzenesulfonamide
|
||||
| Synonyms |
CHEMBL1807789
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H32N8O3S
|
||||
| Canonical SMILES |
Cc1nc(NCCCN2CCOCC2)cc(Nc3cc(n[nH]3)c4cccc(NS(=O)(=O)c5ccccc5)c4)n1
|
||||
| InChI |
InChI=1S/C27H32N8O3S/c1-20-29-25(28-11-6-12-35-13-15-38-16-14-35)19-26(30-20)31-27-18-24(32-33-27)21-7-5-8-22(17-21)34-39(36,37)23-9-3-2-4-10-23/h2-5,7-10,17-19,34H,6,11-16H2,1H3,(H3,28,29,30,31,32,33)
|
||||
| InChIKey |
FMECAVUOMUCKKM-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Aurora kinase A | Target Info | [1587926] | ||
| FL cytokine receptor | Target Info | [1587926] | |||
| Pathway Interaction Database | Aurora B signaling | ||||
| Signaling by Aurora kinases | |||||
| Integrin-linked kinase signaling | |||||
| PLK1 signaling events | |||||
| Aurora A signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.